A New Era for Medical Marijuana: Impact of the Move to Schedule III
December 23, 2025
*May 20, 2026 Update: The FDA has granted “Breakthrough Therapy” Status to Cannabis-Derived Pain Treatment On December 18, 2025, President Donald Trump signed the executive order “Increasing Medical Marijuana and Cannabidiol Research,” marking one of the most significant shifts in federal drug policy in half a century. For the patients and providers at Medical Marijuana […]
Read More







